These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Thyromimetics: a review of recent reports and patents (2004 - 2009). Hirano T; Kagechika H Expert Opin Ther Pat; 2010 Feb; 20(2):213-28. PubMed ID: 20100003 [TBL] [Abstract][Full Text] [Related]
4. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone. Shi Y; Ye H; Link KH; Putnam MC; Hubner I; Dowdell S; Koh JT Biochemistry; 2005 Mar; 44(12):4612-26. PubMed ID: 15779888 [TBL] [Abstract][Full Text] [Related]
5. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta. Hangeland JJ; Doweyko AM; Dejneka T; Friends TJ; Devasthale P; Mellström K; Sandberg J; Grynfarb M; Sack JS; Einspahr H; Färnegårdh M; Husman B; Ljunggren J; Koehler K; Sheppard C; Malm J; Ryono DE Bioorg Med Chem Lett; 2004 Jul; 14(13):3549-53. PubMed ID: 15177471 [TBL] [Abstract][Full Text] [Related]
6. Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core. Compton DR; Carlson KE; Katzenellenbogen JA Bioorg Med Chem Lett; 2004 Nov; 14(22):5681-4. PubMed ID: 15482947 [TBL] [Abstract][Full Text] [Related]
7. A new class of high affinity thyromimetics containing a phenyl-naphthylene core. Hangeland JJ; Friends TJ; Doweyko AM; Mellström K; Sandberg J; Grynfarb M; Ryono DE Bioorg Med Chem Lett; 2005 Oct; 15(20):4579-84. PubMed ID: 16099653 [TBL] [Abstract][Full Text] [Related]
8. Scaffold oriented synthesis. Part 4: design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions. Akritopoulou-Zanze I; Wakefield BD; Gasiecki A; Kalvin D; Johnson EF; Kovar P; Djuric SW Bioorg Med Chem Lett; 2011 Mar; 21(5):1480-3. PubMed ID: 21288717 [TBL] [Abstract][Full Text] [Related]
10. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines. Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967 [TBL] [Abstract][Full Text] [Related]
11. Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141. Garg N; Li YL; Garcia Collazo AM; Litten C; Ryono DE; Zhang M; Caringal Y; Brigance RP; Meng W; Washburn WN; Agback P; Mellström K; Rehnmark S; Rahimi-Ghadim M; Norin T; Grynfarb M; Sandberg J; Grover G; Malm J Bioorg Med Chem Lett; 2007 Aug; 17(15):4131-4. PubMed ID: 17543524 [TBL] [Abstract][Full Text] [Related]
12. 1,3,4-Oxadiazoline derivatives as novel potential inhibitors targeting chitin biosynthesis: design, synthesis and biological evaluation. Ke S; Liu F; Wang N; Yang Q; Qian X Bioorg Med Chem Lett; 2009 Jan; 19(2):332-5. PubMed ID: 19091556 [TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics. Dow RL; Schneider SR; Paight ES; Hank RF; Chiang P; Cornelius P; Lee E; Newsome WP; Swick AG; Spitzer J; Hargrove DM; Patterson TA; Pandit J; Chrunyk BA; LeMotte PK; Danley DE; Rosner MH; Ammirati MJ; Simons SP; Schulte GK; Tate BF; DaSilva-Jardine P Bioorg Med Chem Lett; 2003 Feb; 13(3):379-82. PubMed ID: 12565933 [TBL] [Abstract][Full Text] [Related]
15. Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists. Wang L; Hubert JA; Lee SJ; Pan J; Qian S; Reitman ML; Strack AM; Weingarth DT; MacNeil DJ; Weber AE; Edmondson SD Bioorg Med Chem Lett; 2011 May; 21(10):2911-5. PubMed ID: 21493064 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and fluorescent properties of a new class of heterocycles of isoindole fused imidazoles with phenolic subunits. Das S; Fröhlich R; Pramanik A Org Lett; 2006 Sep; 8(19):4263-6. PubMed ID: 16956202 [TBL] [Abstract][Full Text] [Related]
17. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta. Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia. Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands. Chesworth R; Wessel MD; Heyden L; Mangano FM; Zawistoski M; Gegnas L; Galluzzo D; Lefker B; Cameron KO; Tickner J; Lu B; Castleberry TA; Petersen DN; Brault A; Perry P; Ng O; Owen TA; Pan L; Ke HZ; Brown TA; Thompson DD; DaSilva-Jardine P Bioorg Med Chem Lett; 2005 Dec; 15(24):5562-6. PubMed ID: 16219463 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]